药品上市后效益风险评价方法综述  

作　　者：杨依晗[1,2] 马爱霞[1,2] 

机构地区：[1]中国药科大学国际医药商学院 [2]中国药科大学,南京210009

出　　处：《中国药物经济学》2008年第6期48-54,共7页China Journal of Pharmaceutical Economics

摘　　要：本文旨在了解药品上市后效益风险评价的现有方法。通过对NNT/NNH方法、多属性决策分析、三三原则分级体系和TURBO模型在药品效益风险评价中的运用进行介绍和比较,认为4种方法各有所长,在对药品效益和风险评价思路上存在一定差异。This paper aims at suggesting some current methods of the Benefit-Risk Assessment for marketed drug.It could make a conclusion that these methods,including the NNT/NNH method,Multi-Criteria Decision Analysis,the'Principle of three'grading system and the TURBO models,all have merits,and there are some differences in the approach of drug Benefit-Risk Assessment by introducing and comparing the application of them in this field.

关 键 词：效益 风险 药品 方法 

分 类 号：F407.72[经济管理—产业经济]